Clarkston Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$1.4M |
| 2 |
Walmart Inc
WMT
|
+$1.4M |
| 3 |
WW
WW International
WW
|
+$1.36M |
| 4 |
Western Union
WU
|
+$937K |
| 5 |
Intel
INTC
|
+$897K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$434K |
| 2 |
Thor Industries
THO
|
+$389K |
| 3 |
AT&T
T
|
+$210K |
| 4 |
Becton Dickinson
BDX
|
+$182K |
| 5 |
McDonald's
MCD
|
+$179K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.9% |
| 2 | Consumer Staples | 19.43% |
| 3 | Technology | 16.49% |
| 4 | Industrials | 15.57% |
| 5 | Healthcare | 13.98% |
Similar funds
Clarkston Capital Partners's Q3 2013 Portfolio in Review
As of Q3 2013, Clarkston Capital Partners held 98 positions worth $207M, up 15% from $180M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Clarkston Capital Partners deployed $19.6M of net new capital in Q3 2013, opening 3 new positions and adding to 67 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 10,493 shares worth $757K.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was AT&T, an estimated $210K trimmed.
- Clarkston Capital Partners's largest Q3 2013 buy was BioMarin Pharmaceuticals: 10,493 shares worth $757K.
- Clarkston Capital Partners added most to Sysco in Q3 2013, an estimated $1.4M increase.
- Clarkston Capital Partners's biggest Q3 2013 reduction was AT&T, cutting an estimated $210K.
- Clarkston Capital Partners fully exited Caterpillar in Q3 2013, selling an estimated $434K.
- Clarkston Capital Partners's ten largest holdings make up 38% of its $207M portfolio in Q3 2013.
- Clarkston Capital Partners opened 3 new positions and closed 2 in Q3 2013.
- Clarkston Capital Partners's portfolio value rose 15% quarter-over-quarter to $207M.
Based on Clarkston Capital Partners's 13F filing for Q3 2013, filed 21 Oct 2013.